JP4495599B2 - 抗腫瘍薬の調製のためにヒドロキサム酸誘導体を使用する方法 - Google Patents

抗腫瘍薬の調製のためにヒドロキサム酸誘導体を使用する方法 Download PDF

Info

Publication number
JP4495599B2
JP4495599B2 JP2004566776A JP2004566776A JP4495599B2 JP 4495599 B2 JP4495599 B2 JP 4495599B2 JP 2004566776 A JP2004566776 A JP 2004566776A JP 2004566776 A JP2004566776 A JP 2004566776A JP 4495599 B2 JP4495599 B2 JP 4495599B2
Authority
JP
Japan
Prior art keywords
tumor
leukemia
alkyl
preparation
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004566776A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514659A (ja
JP2006514659A5 (https=
Inventor
レオーニ フラビオ
マスカーニ パオロ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of JP2006514659A publication Critical patent/JP2006514659A/ja
Publication of JP2006514659A5 publication Critical patent/JP2006514659A5/ja
Application granted granted Critical
Publication of JP4495599B2 publication Critical patent/JP4495599B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2004566776A 2003-01-17 2003-12-10 抗腫瘍薬の調製のためにヒドロキサム酸誘導体を使用する方法 Expired - Lifetime JP4495599B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000064A ITMI20030064A1 (it) 2003-01-17 2003-01-17 Uso dei derivati dell'acido idrossamico per la preparazione
PCT/EP2003/014171 WO2004064824A1 (en) 2003-01-17 2003-12-10 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments

Publications (3)

Publication Number Publication Date
JP2006514659A JP2006514659A (ja) 2006-05-11
JP2006514659A5 JP2006514659A5 (https=) 2007-01-11
JP4495599B2 true JP4495599B2 (ja) 2010-07-07

Family

ID=32750476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004566776A Expired - Lifetime JP4495599B2 (ja) 2003-01-17 2003-12-10 抗腫瘍薬の調製のためにヒドロキサム酸誘導体を使用する方法

Country Status (8)

Country Link
US (1) US8227515B2 (https=)
EP (1) EP1583523B1 (https=)
JP (1) JP4495599B2 (https=)
AU (1) AU2003290034A1 (https=)
DE (1) DE60311888T2 (https=)
ES (1) ES2282705T3 (https=)
IT (1) ITMI20030064A1 (https=)
WO (1) WO2004064824A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1392908B1 (it) * 2008-09-29 2012-04-02 Italfarmaco Spa Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
KR20020070285A (ko) * 1999-11-23 2002-09-05 메틸진, 인크. 히스톤 디아세틸라제의 억제제
JPWO2002074298A1 (ja) * 2001-03-21 2004-07-08 小野薬品工業株式会社 Ｉｌ−６産生阻害剤
SE0101257D0 (sv) * 2001-04-06 2001-04-06 A & Science Invest Ab Treatment of whiplash associated disorder
ITMI20011733A1 (it) 2001-08-07 2003-02-07 Italfarmaco Spa Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc
JPWO2003070691A1 (ja) * 2002-02-21 2005-06-09 財団法人大阪産業振興機構 Ｎ−ヒドロキシカルボキサミド誘導体

Also Published As

Publication number Publication date
DE60311888D1 (de) 2007-03-29
EP1583523B1 (en) 2007-02-14
EP1583523A1 (en) 2005-10-12
AU2003290034A1 (en) 2004-08-13
US20060063800A1 (en) 2006-03-23
DE60311888T2 (de) 2007-12-06
JP2006514659A (ja) 2006-05-11
WO2004064824A1 (en) 2004-08-05
ES2282705T3 (es) 2007-10-16
US8227515B2 (en) 2012-07-24
ITMI20030064A1 (it) 2004-07-18

Similar Documents

Publication Publication Date Title
JP2024063227A (ja) 肥満細胞症の治療のための併用療法
DK2739153T3 (en) TREATMENT OF BREAST CANCER
EP3148536B1 (en) Pharmaceutical combinations for treating cancer
JP2001519366A (ja) ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法
JP2022534979A (ja) 置換１－オキソ－イソインドリン－５－カルボキサミド化合物、その組成物、およびそれによる治療方法
TWI482621B (zh) 青蒿素基藥物與其他化學治療劑的抗癌組合物
JP2003530297A (ja) Ｖｉｐアンタゴニストを用いる併用療法
CN101273989A (zh) 一类小檗胺衍生物及其盐的应用
US6262093B1 (en) Methods of treating cancer with benzimidazoles
EP3378473A1 (en) Drug combination having anti-tumor efficacy
WO2001060370A1 (en) Remedies for endothelin-induced diseases
JP4495599B2 (ja) 抗腫瘍薬の調製のためにヒドロキサム酸誘導体を使用する方法
AU2015266552A1 (en) Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient
CN112089710B (zh) 4-羟基异亮氨酸在制备抗肿瘤药物中的应用
KR101847252B1 (ko) 이리노테칸염산염 수화물을 함유하는 항종양제
CN110354261B (zh) 喹唑啉类化合物与阿瓦斯汀在制备防止疾病的联合用药物中的用途
WO2018058863A1 (zh) 聚醚类化合物用途
EP2902028A1 (en) Drug composition for treating tumors and application thereof
BRPI0717998A2 (pt) Método para administrar um composto antitumor.
EP1605937A1 (en) Treatment of proliferative diseases with epothilone derivatives and radiation
US20240238223A1 (en) Use of methylaminocolchicine and salt thereof
JPH03170434A (ja) 抗ガン剤相乗剤
CN101230037A (zh) 一种抗癌药物化合物及其合成方法
TWI228417B (en) A composition for inhibiting neoplastic cells
WO2021196335A1 (zh) Pyr3的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061108

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100402

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100409

R150 Certificate of patent or registration of utility model

Ref document number: 4495599

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130416

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130416

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140416

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term